Nazione: Armenia
Lingua: inglese
Fonte: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
vincamine
GlaxoSmithKline S.A.E.
C04AX07
vincamine
30mg
capsules sustained-release
(20/2x10/) blisters
Prescription
Registered
2015-05-15
SMPC FOR OXYBRAL (VINCAMINE) NAME OF THE MEDICINAL PRODUCT Oxybral, sustained release capsule, 30 mg QUALITATIVE AND QUANTITATIVE COMPOSITION _Vincamine, sustained release capsule, 30 mg _ Each sustained release capsule contains 30 mg of vincamine EXCIPIENTS _Vincamine, sustained release capsule, 30 mg _ Sugar microspheres, Lactose, Methacrylic acid co- polymer, (Eudragit L), Povidone, Shellac, Talc, Gelatin, Erythrosine [E127], Indigotine (E 132) PHARMACEUTICAL FORM _Vincamine, sustained release capsule, 30 mg _ Hard gelatin capsules; colourless, transparent body and blue lid; capsule content: white microspheres. CLINICAL INFORMATION INDICATIONS Vincamine is indicated to normalize and adapt the cerebral blood flow according to the metabolic needs and in turn improves, regulates and maintains all the brain functions, reflecting better performance physically and intellectually. Cerebral disorders in the elderly, such as: memory disorders concentration disorders attention and perception disorders Degenerative trophic disorders: diabetes mellitus atherosclerosis After acute cerebral injury: post-traumatic post-apoplectic hypertensive encephalopathy Dizziness, vertigo, headaches of vascular origin and migraine Hearing disorders of vascular origin Visual disorders of vascular origin Mental disorders: temporal and spatial orientation mood disorders cerebro-vascular disorders, particularly cerebral ischemia Improving the intellectual capacity DOSAGE AND ADMINISTRATION ROUTE OF ADMINISTRATION _Vincamine, sustained release capsule, 30 mg _ For oral use ADULTS AND ELDERLY _Vincamine, sustained release capsule, 30 mg _ One capsule twice daily RENAL IMPAIRMENT There are no relevant data available. HEPATIC IMPAIRMENT Although an impairment of the hepatic function was not observed, it should be monitored in long-term vincamine treatment. CONTRAINDICATIONS Vincamine is contraindicated in: intracranial tumors (or diseases related to increased intracr Leggi il documento completo